TECHNOPATH partner with Luminex® Corporation to offer a comprehensive range of molecular assays for respiratory, gastrointestinal and bloodstream testing, in addition to womens’ health.
Luminex® is the only molecular diagnostics developer providing both targeted and syndromic clinical tests for infectious diseases — so you never have to compromise on diagnostic performance, cost, or turnaround time to generate results.
From low-volume microbiology labs to high-capacity reference labs and everything in between, Luminex® offers flexible solutions to meet the clinical, operational, and economical needs of your healthcare system.
Molecular SARS-CoV-2 Testing Solutions
NxTAG® CoV Extended Panel is a high-throughput, more comprehensive option for high-complexity labs, which can detect SARS-CoV-2. Developed for use on the MAGPIX® NxTAG-enabled System. SARS-CoV-2 detection using three viral genes (ORF1ab, E gene, and N gene), enabling accurate, reliable results.
For more targeted coronavirus testing in moderate-complexity labs, the ARIES® SARS-CoV-2 Assay is a sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs, and now has received an EUA from the FDA.